Impact of Socioeconomic Status on Clinical Outcomes in Patients With ST-Segment-Elevation Myocardial Infarction

S Biswas; N Andrianopoulos; SJ Duffy; J Lefkovits; A Brennan; A Walton; W Chan; S Noaman; JA Shaw; A Ajani; DJ Clark; M Freeman; C Hiew; E Oqueli; CM Reid; D Stub

Journal article

Impact of Socioeconomic Status on Clinical Outcomes in Patients With ST-Segment-Elevation Myocardial Infarction

S Biswas, N Andrianopoulos, SJ Duffy, J Lefkovits, A Brennan, A Walton, W Chan, S Noaman, JA Shaw, A Ajani, DJ Clark, M Freeman, C Hiew, E Oqueli, CM Reid, D Stub

Circulation Cardiovascular Quality and Outcomes | LIPPINCOTT WILLIAMS & WILKINS | Published : 2019

DOI: 10.1161/CIRCOUTCOMES.118.004979

Abstract

BACKGROUND: Low socioeconomic status (SES) has been previously shown to be associated with worse cardiovascular outcomes. However, unlike in Australia, many of these studies have been performed in countries without universal healthcare where SES may be expected to have a greater impact on care and outcomes. We sought to determine whether there is an association between SES and baseline characteristics, clinical outcomes and use of secondary prevention therapy in patients with ST-segment-elevation myocardial infarction undergoing percutaneous coronary intervention (PCI). METHODS AND RESULTS: We prospectively collected data on 5665 consecutive ST-segment-elevation myocardial infarction PCI pat..

View full abstract

University of Melbourne Researchers

William Chan Author

David Clark Author

Related Projects (1)

CENTRE OF RESEARCH EXCELLENCE IN CARDIOVASCULAR OUTCOMES IMPROVEMENT

Quality, safety and the effectiveness of providing prevention and treatments to those with cardiovascular disease is the focus of research o..

Grants

Awarded by National Heart Foundation of Australia

Awarded by National Health and Medical Research Council

Awarded by National Health and Medical Research Council of Australia

Funding Acknowledgements

We acknowledge the following sources of scholarship/grant support: The National Heart Foundation of Australia (Dr Biswas: reference number 101518 and Dr Stub: reference number 101908), the Australian Government Research Training Program (Dr Biswas), the National Health and Medical Research Council (Dr Duffy: reference number 1111170; Dr Chan: reference number 1052960; and Dr Reid: reference number 1045862), and the Viertel Foundation Clinical Investigator Award (Dr Stub). The Melbourne Interventional Group registry acknowledges funding from Abbott, Astra-Zeneca, Medtronic, MSD, Pfizer, Servier, and The Medicines Company. These companies do not have access to data and do not have the right to review articles or abstracts before publication.